CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleMarket cap is $1.54B, above the global median of $1.15B
- FinancialsAltman Z-Score 4.2: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.16%Below 5Y avg (0.42%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
7.7%Sustainable
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
10.35BCNY1.54B · vs all stocks (USD)
Trailing P/E
66.68xvs Scientific & Technical Instruments peers
Revenue (TTM)
2.32BCNY344.51M · vs all stocks (USD)
Profit Margin
7.18%vs Scientific & Technical Instruments peers
Beta
0.6730xvs all stocks
52-Week Change
-32.16%vs all stocks
Market Capitalization
10.35BCNY1.54B · vs all stocks (USD)
Enterprise Value
12.07BCNY1.79B · vs all stocks (USD)
Trailing P/E
66.68xvs Scientific & Technical Instruments peers
Forward P/E
25.61xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
4.99xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
3.92xvs Scientific & Technical Instruments peers
Enterprise to Revenue
5.20xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
58.88xvs Scientific & Technical Instruments peers
Gross Margin
34.06%vs Scientific & Technical Instruments peers
Profit Margin
7.18%vs Scientific & Technical Instruments peers
Operating Margin
5.11%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
0.49%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
4.87%vs Scientific & Technical Instruments peers
Revenue (TTM)
2.32BCNY344.51M · vs all stocks (USD)
Revenue per Share (TTM)
7.32CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-15.60%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
774.20MCNY114.98M · vs all stocks (USD)
EBITDA (TTM)
275.76MCNY40.96M · vs all stocks (USD)
Net Income (TTM)
166.62MCNY24.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
46.10%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
62.44MCNY9.27M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-263.91MCNY-39.20M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.16%vs all stocks
5-Year Average Dividend Yield
0.42%vs all stocks
Payout Ratio
7.69%vs Scientific & Technical Instruments peers
Minority Interest (Equity)
129.23MCNYFY2025 · Dec 31, 2025Revenue
2.41BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.66BCNYFY2025 · Dec 31, 2025Gross Profit
755.43MCNYFY2025 · Dec 31, 2025Operating Income
208.23MCNY30.93M · vs all stocks (USD)
Pre-tax Income
202.29MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.67MCNYFY2025 · Dec 31, 2025Net Income
151.62MCNYFY2025 · Dec 31, 2025EBIT
227.99MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
467.60MCNYFY2025 · Dec 31, 2025Research & Development
234.87MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
158.27MCNYFY2025 · Dec 31, 2025Other Operating Expenses
23.73MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.83MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
25.70MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4900CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4900CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
324.11MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
324.11MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
151.62MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
7.20MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-160.19MCNYFY2025 · Dec 31, 2025Free Cash Flow
-363.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
594.23MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
151.62MCNYFY2025 · Dec 31, 2025Other Non-cash Items
41.04MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-261.68MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-91.17MCNYFY2025 · Dec 31, 2025Capital Expenditures
-203.69MCNYFY2025 · Dec 31, 2025Net Acquisitions
-22.64MCNYFY2025 · Dec 31, 2025Purchase of Investments
-270.16MCNYFY2025 · Dec 31, 2025Sale of Investments
234.71MCNYFY2025 · Dec 31, 2025Other Investing Activity
-12.52MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-274.30MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
607.27MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-492.08MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-37.49MCNYFY2025 · Dec 31, 2025Other Financing Charges
15.47MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
93.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
327.45MSharesUpdated Aug 19, 2026Float Shares
249.77MSharesUpdated Aug 19, 2026% Held by Insiders
22.57%vs all stocks
% Held by Institutions
7.03%vs all stocks
Total Cash (MRQ)
664.31MCNY98.66M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.03CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.04BCNY154.18M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3374xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
1.80xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
9.02CNYUpdated Aug 19, 2026Total Assets
5.16BCNY766.71M · vs all stocks (USD)
Total Current Assets
2.98BCNYFY2025 · Dec 31, 2025Total Liabilities
2.10BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.19BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
395.80MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.71BCNYFY2025 · Dec 31, 2025Cash
599.34MCNYFY2025 · Dec 31, 2025Cash Equivalents
23.62MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
622.96MCNYFY2025 · Dec 31, 2025Other Short-term Investments
15.00MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.45BCNYFY2025 · Dec 31, 2025Inventory
562.29MCNYFY2025 · Dec 31, 2025Accounts Payable
687.14MCNYFY2025 · Dec 31, 2025Short-term Debt
740.02MCNYFY2025 · Dec 31, 2025Other Current Liabilities
33.45MCNYFY2025 · Dec 31, 2025Long-term Debt
270.00MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
3.53MCNYFY2025 · Dec 31, 2025Common Stock (Book)
327.45MCNYFY2025 · Dec 31, 2025Retained Earnings
1.26BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.06BCNY454.44M · vs all stocks (USD)
52-Week Low
29.45CNYUpdated Aug 19, 202652-Week High
73.00CNYUpdated Aug 19, 202652-Week Change
-32.16%vs all stocks
Beta
0.6730xvs all stocks
50-Day MA
36.43CNYUpdated Aug 19, 2026200-Day MA
46.14CNYUpdated Aug 19, 2026Avg 10-Day Volume
10.90MSharesUpdated Aug 19, 2026Avg 30-Day Volume
11.89MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.5300CNYUpdated Aug 19, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 24,746,392.895Operating Cash Flow (USD, TTM): 9,273,827.62
Financial Health
Altman Z-Score 4.2: safe zoneNotable
Altman Z-Score: 4.20
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Market cap is $1.54B, above the global median of $1.15BNotable
Market cap (USD): 1,537,750,901.701Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Akr Corporindo Tbk
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinfonia Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRiskSenseMaking
Alpek, S.A.B. de C.V.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Linuo Pharmaceutical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Fenglong Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
SkyWater Technology, Inc.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Guangzhou Lingwe Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Poongsan Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dongfeng Automobile Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
East Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
LG Innotek Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedReceivables Heavy and Growing
Hynar Water Group Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedReceivables Heavy and Growing
Savannah Energy PLC
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedReceivables Heavy and Growing